Related Experiment Video

Updated: Jun 10, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

17.4K

Present and Future of Immunotherapy for Triple-Negative Breast Cancer

Sushmitha Sriramulu1, Shivani Thoidingjam1, Corey Speers2,3

  • 1Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI 48202, USA.

Cancers
|October 16, 2024
PubMed

Insights

Triple-negative breast cancer (TNBC) shows promise for immunotherapy due to PD-L1 expression. Combination strategies are being explored to improve response rates for this aggressive cancer.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Triple-negative breast cancer (TNBC) lacks estrogen receptors (ERs), HER2, and progesterone receptors (PRs), presenting a poor prognosis.
  • TNBC exhibits higher PD-L1 expression and tumor-infiltrating lymphocytes, suggesting potential for immunotherapy.
  • Current immunotherapy, like pembrolizumab with chemotherapy, has improved outcomes but not for all patients.

Purpose of the Study:

  • To review the current landscape of immunotherapy in TNBC.
  • To explore combination strategies to enhance immunotherapy response rates.
  • To discuss emerging immunotherapeutic opportunities for TNBC.

Main Methods:

  • Literature review of TNBC and immunotherapy.
  • Analysis of current and investigational immunotherapy strategies.
  • Evaluation of combination therapies (chemotherapy, targeted therapy, radiotherapy).

Main Results:

  • Immunotherapy, particularly pembrolizumab, has shown efficacy in advanced TNBC.
  • Combination strategies are crucial for improving response rates in a broader patient population.
  • Several novel immunotherapeutic agents are under investigation.

Conclusions:

  • Immunotherapy represents a significant advancement in TNBC treatment.
  • Combination strategies are essential to overcome current limitations and improve patient outcomes.
  • Future research holds promise for new therapeutic approvals in TNBC.
Keywords:
TNBCchemotherapyimmune checkpoint inhibitorsimmunotherapyradiation therapytriple-negative breast cancer

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2